Stay updated on Anti-IL-5 Therapy in Bullous Pemphigoid Clinical Trial
Sign up to get notified when there's something new on the Anti-IL-5 Therapy in Bullous Pemphigoid Clinical Trial page.

Latest updates to the Anti-IL-5 Therapy in Bullous Pemphigoid Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page shows a software revision update from v3.2.0 to v3.3.2, with no changes to core study content or participant information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange DetectedRemoved a generic government funding and operating status notice from the page. The notice was a site-wide informational message and does not affect the study details.SummaryDifference0.4%

- Check42 days agoChange DetectedNo significant changes were detected between the two screenshots; the page content and layout appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check71 days agoChange DetectedCore content updated with a government-operating-status notice and a version upgrade to v3.2.0, replacing the previous v3.1.0.SummaryDifference4%

- Check78 days agoChange DetectedThe page now shows Revision: v3.1.0 and removes several drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) from the content, indicating a restructuring and possible narrowing of the domain coverage.SummaryDifference0.5%

- Check92 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.SummaryDifference0.3%

Stay in the know with updates to Anti-IL-5 Therapy in Bullous Pemphigoid Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anti-IL-5 Therapy in Bullous Pemphigoid Clinical Trial page.